Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017.

  title={Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017.},
  author={C. Hiemke and N. Bergemann and H. W. Clement and A. Conca and J. Deckert and K. Domschke and G. Eckermann and K. Egberts and M. Gerlach and C. Greiner and G. Gr{\"u}nder and E. Haen and U. Havemann-Reinecke and G. Hefner and R. Helmer and G. Janssen and E. Jaquenoud and G. Laux and T. Messer and R. Moessner and M. M{\"u}ller and M. Paulzen and B. Pfuhlmann and P. Riederer and A. Saria and B. Schoppek and G. Schoretsanitis and M. Schwarz and M. S. Gracia and B. Stegmann and W. Steimer and J. Stingl and M. Uhr and S. Ulrich and S. Unterecker and R. Waschgler and G. Zernig and G. Zurek and P. Baumann},
  volume={51 1-02},
  • C. Hiemke, N. Bergemann, +36 authors P. Baumann
  • Published 2018
  • Medicine
  • Pharmacopsychiatry
  • Authors C. Hiemke1, 2, N. Bergemann3, H. W. Clement4, A. Conca5, J. Deckert6, K. Domschke7, G. Eckermann8, K. Egberts9, M. Gerlach9, C. Greiner10, G. Gründer11, E. Haen12, U. Havemann-Reinecke13, G. Hefner14, R. Helmer15, G. Janssen16, E. Jaquenoud17, G. Laux18, T. Messer19, R. Mössner20, M. J. Müller21, M. Paulzen11, B. Pfuhlmann22, P. Riederer6, A. Saria23, B. Schoppek24, G. Schoretsanitis25, M. Schwarz26, M. Silva Gracia12, B. Stegmann12, W. Steimer27, J. C. Stingl10, M. Uhr28, S. Ulrich29… CONTINUE READING
    54 Citations
    Impact of CYP2C19 genotype on sertraline exposure in 1200 Scandinavian patients
    • 1
    Determination of plasma concentration reference ranges for oral aripiprazole, olanzapine, and quetiapine
    • 4
    Reduced clearance of venlafaxine in a combined treatment with quetiapine
    • 9
    Comedication of Valproic Acid Is Associated With Increased Metabolism of Clozapine
    • 6


    Elevated clozapine serum levels in combination with perazine
    • 6
    Clobazam Therapeutic Drug Monitoring: A Comprehensive Review of the Literature With Proposals to Improve Future Studies
    • 54
    • Highly Influential
    Rasagiline (TVP-1012): a new selective monoamine oxidase inhibitor for Parkinson's disease.
    • D. Guay
    • Medicine
    • The American journal of geriatric pharmacotherapy
    • 2006
    • 78
    • Highly Influential
    The in vivo response of novel buprenorphine metabolites, M1 and M3, to antiretroviral inducers and inhibitors of buprenorphine metabolism.
    • 30
    • Highly Influential
    Effects of 22 novel CYP2D6 variants found in Chinese population on the metabolism of dapoxetine
    • 5
    • Highly Influential
    • PDF
    Relevant issues in the monitoring and the toxicology of antidepressants.
    • 45